Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other ...
On December 18, 2025, Werewolf Therapeutics, Inc. (NASDAQ:HOWL) shared a comprehensive pipeline update in which it highlighted clinical progress and 2026 priorities for its INDUKINE programs and ...
It was a presentation at the American Society of Hematology (ASH) conference that swayed Jazz Pharmaceuticals to put up $15 million upfront to join Werewolf Therapeutics on the prowl. The backloaded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results